BEIGF - BeOne Medicines' sonrotoclax gets FDA breakthrough therapy status
2025-10-13 09:08:36 ET
More on BeiGene
- BeOne Medicines AG (ONC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)
- BeOne Medicines: Brukinsa's Leadership And Royalty Sale Signal A Stronger Future
- BeOne Medicines Ltd. 2025 Q2 - Results - Earnings Call Presentation
- Trump’s 100% drug tariffs send pharma stocks lower
- BeOne Medicines succeeds in Phase 1/2 study for lymphoma therapy